| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Pranoti S. Mandrekar | Q68342340 |
| P2093 | author name string | Gyongyi Szabo | |
| P2860 | cites work | MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 | Q22009943 |
| Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice | Q24170238 | ||
| Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages | Q24296276 | ||
| Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4 | Q24555143 | ||
| TLR signaling pathways | Q24570127 | ||
| LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF | Q24672442 | ||
| Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins | Q27860890 | ||
| Pathogen recognition and innate immunity | Q27861084 | ||
| Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B | Q28118928 | ||
| Signaling through the JAK/STAT pathway, recent advances and future challenges | Q28201804 | ||
| Toll-like receptors in innate immunity | Q28297257 | ||
| Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability | Q28508664 | ||
| Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress | Q28512203 | ||
| ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding | Q28572528 | ||
| Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway | Q28592087 | ||
| The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation | Q29400446 | ||
| CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein | Q29615189 | ||
| AP-1 in cell proliferation and survival | Q29615217 | ||
| Negative regulation of toll-like receptor-mediated immune responses | Q29619019 | ||
| Regulation of inducible gene expression by the transcription factor NF-kappaB. | Q33736018 | ||
| Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes | Q33977596 | ||
| Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis | Q34072530 | ||
| Interleukin-10 therapy--review of a new approach | Q35139563 | ||
| Of JAKs, STATs, blind watchmakers, jeeps and trains | Q35163904 | ||
| Recent insights into the role of the innate immune system in the development of alcoholic liver disease. | Q35216526 | ||
| Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. | Q35832836 | ||
| Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. | Q35931527 | ||
| Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. | Q35962828 | ||
| Acute exposure to ethanol affects Toll-like receptor signaling and subsequent responses: an overview of recent studies | Q35982214 | ||
| Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding | Q35989242 | ||
| Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activation | Q36003091 | ||
| Adaptor usage and Toll-like receptor signaling specificity | Q36117637 | ||
| Ethanol-induced liver injury: potential roles for egr-1. | Q36339578 | ||
| Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum | Q36352797 | ||
| Pattern recognition receptors: a contemporary view on liver diseases. | Q36548470 | ||
| Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury | Q36645721 | ||
| Regulation of macrophage activation in alcoholic liver disease | Q36849050 | ||
| High glucose induces toll-like receptor expression in human monocytes: mechanism of activation | Q36943779 | ||
| TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol | Q36949218 | ||
| Mechanisms for the anti-inflammatory effects of adiponectin in macrophages | Q37108874 | ||
| Toll-like receptors and adaptor molecules in liver disease: update | Q37174620 | ||
| Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations | Q37356770 | ||
| NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease | Q37526716 | ||
| Increased lipopolysaccharide sensitivity in alcoholic fatty livers is independent of leptin deficiency and toll-like receptor 4 (TLR4) or TLR2 mRNA expression | Q38324517 | ||
| Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice | Q40206519 | ||
| S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease | Q40512960 | ||
| Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. | Q40527459 | ||
| Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization | Q40548048 | ||
| Chronic ethanol increases lipopolysaccharide-stimulated Egr-1 expression in RAW 264.7 macrophages: contribution to enhanced tumor necrosis factor alpha production | Q40749420 | ||
| Stabilization of tumor necrosis factor alpha mRNA by chronic ethanol: role of A + U-rich elements and p38 mitogen-activated protein kinase signaling pathway | Q40781194 | ||
| Tumor necrosis factor and alcoholic liver disease | Q40844196 | ||
| Hepatic sinusoidal endothelial cell in alcoholemia and endotoxemia | Q40937686 | ||
| Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction | Q40962119 | ||
| Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors | Q41099730 | ||
| Tumor necrosis factor in alcohol enhanced endotoxin liver injury | Q41914272 | ||
| Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation. | Q42282216 | ||
| Increased tumor necrosis factor production by monocytes in alcoholic hepatitis | Q42505321 | ||
| Reduced early alcohol-induced liver injury in CD14-deficient mice | Q43545368 | ||
| Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-kappaB activation and cytokine production. | Q43580537 | ||
| Ethanol inhibits the JAK-STAT signaling pathway in freshly isolated rat hepatocytes but not in cultured hepatocytes or HepG2 cells: evidence for a lack of involvement of ethanol metabolism | Q43641253 | ||
| Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice | Q43657691 | ||
| A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide | Q43872901 | ||
| Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice | Q43909493 | ||
| Dilinoleoylphosphatidylcholine decreases LPS-induced TNF-alpha generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NF-kappaB. | Q44025407 | ||
| Acute alcohol inhibits the induction of nuclear regulatory factor kappa B activation through CD14/toll-like receptor 4, interleukin-1, and tumor necrosis factor receptors: a common mechanism independent of inhibitory kappa B alpha degradation? | Q44219386 | ||
| Up-regulation of CD14 in liver caused by acute ethanol involves oxidant-dependent AP-1 pathway | Q44249788 | ||
| In vivo ethanol exposure down-regulates TLR2-, TLR4-, and TLR9-mediated macrophage inflammatory response by limiting p38 and ERK1/2 activation | Q45195947 | ||
| CD14 is required for MyD88-independent LPS signaling. | Q45990170 | ||
| The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. | Q46367336 | ||
| Fat diet and alcohol-induced steatohepatitis after LPS challenge in mice: role of bioactive TNF and Th1 type cytokines | Q46414361 | ||
| Moderate alcohol intake in humans attenuates monocyte inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of interleukin 10. | Q46909253 | ||
| Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin | Q47787116 | ||
| Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. | Q48007469 | ||
| Essential role of MD-2 in LPS responsiveness and TLR4 distribution. | Q50109313 | ||
| II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. | Q50864303 | ||
| TLR2- and TLR4-mediated signals determine attenuation or augmentation of inflammation by acute alcohol in monocytes. | Q51807119 | ||
| Alcohol-induced regulation of nuclear regulatory factor-kappa beta in human monocytes. | Q52527307 | ||
| Acute alcohol activates STAT3, AP-1, and Sp-1 transcription factors via the family of Src kinases to promote IL-10 production in human monocytes | Q57375031 | ||
| Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients | Q68198337 | ||
| Regulation of human monocyte functions by acute ethanol treatment: decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production | Q71672956 | ||
| Human monocyte IL-10 production is increased by acute ethanol treatment | Q71725675 | ||
| Cytokines and alcoholic liver disease | Q72847010 | ||
| Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat | Q73023401 | ||
| Inhibition of lipopolysaccharide-mediated NFkappaB activation by ethanol in human monocytes | Q73142401 | ||
| Tolerance and sensitization to endotoxin in Kupffer cells caused by acute ethanol involve interleukin-1 receptor-associated kinase | Q73149415 | ||
| Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells | Q73322874 | ||
| Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance | Q73769805 | ||
| Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis | Q73792877 | ||
| Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat | Q73939862 | ||
| Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes | Q77137033 | ||
| Heme oxygenase-1 mediates the anti-inflammatory effects of acute alcohol on IL-10 induction involving p38 MAPK activation in monocytes | Q80058051 | ||
| Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver | Q83182716 | ||
| P433 | issue | 6 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 1258-1266 | |
| P577 | publication date | 2009-03-28 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Signalling pathways in alcohol-induced liver inflammation | |
| P478 | volume | 50 |
| Q36228676 | A Single Nucleotide Polymorphism in the RASGRF2 Gene Is Associated with Alcoholic Liver Cirrhosis in Men. |
| Q38604295 | A Systems Biology Approach to Understanding Alcoholic Liver Disease Molecular Mechanism: The Development of Static and Dynamic Models |
| Q35201613 | Aberrant hepatic methionine metabolism and gene methylation in the pathogenesis and treatment of alcoholic steatohepatitis |
| Q39727242 | Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. |
| Q42954549 | Activation of NF-κB after chronic ethanol intake and haemorrhagic shock/resuscitation in mice |
| Q30500334 | Activation of inflammatory signaling by lipopolysaccharide produces a prolonged increase of voluntary alcohol intake in mice. |
| Q43535534 | Additive effect of alpha-tocopherol and ascorbic acid in combating ethanol-induced hepatic fibrosis. |
| Q36578908 | Adipose tissue-liver axis in alcoholic liver disease |
| Q28834514 | Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease |
| Q82511125 | Advances in alcoholic liver disease |
| Q47165536 | Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame |
| Q33859008 | Alcohol and acetaldehyde in public health: from marvel to menace |
| Q26773204 | Alcohol's Effect on Host Defense |
| Q39316673 | Alcohol, aging, and innate immunity |
| Q50600015 | Alcohol-induced miR-155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease. |
| Q34405030 | Alcoholic disease: liver and beyond. |
| Q38759707 | Alcoholic hepatitis: Translational approaches to develop targeted therapies |
| Q37711304 | Alcoholic liver disease and the gut-liver axis |
| Q27014123 | Alcoholic pancreatitis: A tale of spirits and bacteria |
| Q51746034 | Aloin protects against chronic alcoholic liver injury via attenuating lipid accumulation, oxidative stress and inflammation in mice. |
| Q90224023 | An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation |
| Q35930080 | An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. |
| Q33632098 | Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritis |
| Q39391427 | Beneficial Role of Citrus Fruit Polyphenols Against Hepatic Dysfunctions: A Review |
| Q36798710 | Binge ethanol and liver: new molecular developments |
| Q84514529 | Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice |
| Q46556481 | Carnosic acid alleviates chronic alcoholic liver injury by regulating the SIRT1/ChREBP and SIRT1/p66shc pathways in rats |
| Q57846940 | Cerebrospinal Fluid Monocyte Chemoattractant Protein-1 in Alcoholics: Support for a Neuroinflammatory Model of Chronic Alcoholism |
| Q36111630 | Changes in mitochondrial DNA and its encoded products in alcoholic cirrhosis. |
| Q33837498 | Chinese medicinal formula, Qinggan Huoxue Recipe protects rats from alcoholic liver disease via the lipopolysaccharide-Kupffer cell signal conduction pathway |
| Q28082228 | Chronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunction |
| Q35040048 | Chronic alcohol exposure exacerbates inflammation and triggers pancreatic acinar-to-ductal metaplasia through PI3K/Akt/IKK |
| Q35783979 | Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis |
| Q41965191 | Chronic ethanol feeding modulates inflammatory mediators, activation of nuclear factor-κB, and responsiveness to endotoxin in murine Kupffer cells and circulating leukocytes. |
| Q37707790 | Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver. |
| Q48944904 | Correction of all-trans retinoic acid deficiency in alcoholic cirrhosis lessens the excessive inflammatory monocyte response: a translational study. |
| Q51708374 | Decreased expression of mitochondrial aldehyde dehydrogenase-2 induces liver injury via activation of the mitogen-activated protein kinase pathway. |
| Q36540069 | Deletion of tumor progression locus 2 attenuates alcohol-induced hepatic inflammation |
| Q90644227 | Dietary fiber and chicken microbiome interaction: Where will it lead to? |
| Q51726720 | Dietary nucleotides protect against alcoholic liver injury by attenuating inflammation and regulating gut microbiota in rats. |
| Q42921175 | DietaryRRR-α-tocopherol succinate attenuates lipopolysaccharide-induced inflammatory cytokines secretion in broiler chicks |
| Q39039913 | Diethylcarbamazine: possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice |
| Q33820683 | Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice |
| Q34490057 | Dynamic changes of lipopolysaccharide levels in different phases of acute on chronic hepatitis B liver failure |
| Q39692028 | Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis |
| Q39514629 | Elephantopus scaber inhibits lipopolysaccharide-induced liver injury by suppression of signaling pathways in rats |
| Q38869806 | Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats |
| Q38193602 | Endoplasmic reticulum stress in drug- and environmental toxicant-induced liver toxicity |
| Q27023122 | Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stress |
| Q33914854 | Epigenetic Interactions between Alcohol and Cannabinergic Effects: Focus on Histone Modification and DNA Methylation |
| Q38169189 | Epigenetic effects of ethanol on the liver and gastrointestinal system |
| Q35012703 | Epigenetic regulation in alcoholic liver disease. |
| Q37386440 | Epigenetic targets for reversing immune defects caused by alcohol exposure |
| Q28383305 | Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1 |
| Q27010130 | Evolving roles of circadian rhythms in liver homeostasis and pathology |
| Q41043694 | Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease |
| Q92422244 | Extracellular Signal-Regulated Kinase: A Regulator of Cell Growth, Inflammation, Chondrocyte and Bone Cell Receptor-Mediated Gene Expression |
| Q58562856 | FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice |
| Q34070485 | Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART |
| Q37386702 | Focus on: Alcohol and the liver |
| Q33616976 | Fructose Consumption in the Development of Obesity and the Effects of Different Protocols of Physical Exercise on the Hepatic Metabolism |
| Q35875885 | Gardenia jasminoides extracts and gallic acid inhibit lipopolysaccharide-induced inflammation by suppression of JNK2/1 signaling pathways in BV-2 cells. |
| Q34438436 | Genetic deletion of AEG-1 prevents hepatocarcinogenesis. |
| Q33681743 | Genetics and genomics of alcohol sensitivity |
| Q37743491 | Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway |
| Q64978993 | Granulocytic myeloid-derived suppressor cell population increases with the severity of alcoholic liver disease. |
| Q39333658 | Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. |
| Q41853896 | HMGB1 recruits hepatic stellate cells and liver endothelial cells to sites of ethanol-induced parenchymal cell injury |
| Q34147508 | Hepatocyte Death: A Clear and Present Danger |
| Q44388928 | Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors |
| Q104461441 | Hepatoprotective effect of crude polysaccharide isolated from Lycium barbarum L. against alcohol-induced oxidative damage involves Nrf2 signaling |
| Q41961138 | Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1. |
| Q37424578 | Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis. |
| Q64266669 | IL-1 beta-mediated macrophage-hepatocyte crosstalk upregulates hepcidin under physiological low oxygen levels |
| Q84654213 | Immune mechanisms in alcoholic liver disease |
| Q36104223 | Immunity and inflammatory signaling in alcoholic liver disease |
| Q103836845 | Immunological mechanisms and therapeutic targets of fatty liver diseases |
| Q43461346 | Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice |
| Q38960163 | Impact of the Innate Immune Response in the Actions of Ethanol on the Central Nervous System |
| Q35814440 | Increased Sensitivity to Binge Alcohol-Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats |
| Q38521274 | Inflammasome activation and function in liver disease |
| Q35402168 | Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice |
| Q36333430 | Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocelular apoptosis. |
| Q34036392 | Inhibition of TLR8- and TLR4-induced Type I IFN induction by alcohol is different from its effects on inflammatory cytokine production in monocytes |
| Q39682952 | Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease |
| Q38053020 | Innate immunity and alcoholic liver disease. |
| Q39077570 | Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases. |
| Q91863736 | Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease |
| Q34187979 | Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease |
| Q34521006 | Involvement of hepatic innate immunity in alcoholic liver disease |
| Q35915822 | Kinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesis |
| Q41681437 | Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function. |
| Q48234896 | LKB1/AMPK-Mediated Regulation by Gentiopicroside Ameliorates P2x7R-Dependent Alcoholic Hepatosteatosis. |
| Q28382981 | Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model |
| Q35535851 | Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice |
| Q36488875 | Large adipocytes function as antigen-presenting cells to activate CD4(+) T cells via upregulating MHCII in obesity |
| Q92212809 | Linderae radix ethanol extract attenuates alcoholic liver injury via attenuating inflammation and regulating gut microbiota in rats |
| Q47382531 | Lipopolysaccharide-Induced Increase in Intestinal Epithelial Tight Permeability Is Mediated by Toll-Like Receptor 4/Myeloid Differentiation Primary Response 88 (MyD88) Activation of Myosin Light Chain Kinase Expression |
| Q50099732 | Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma. |
| Q42535786 | Lutein prevents alcohol-induced liver disease in rats by modulating oxidative stress and inflammation |
| Q55278061 | Managing portal hypertension in patients with liver cirrhosis. |
| Q36151019 | Markers of inflammation and mortality in a cohort of patients with alcohol dependence |
| Q37111252 | Mechanism of Hepatoprotective Effect of Boesenbergia rotunda in Thioacetamide-Induced Liver Damage in Rats |
| Q37127404 | Mechanisms and cell signaling in alcoholic liver disease |
| Q35012716 | Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients |
| Q26849253 | Mechanisms of liver involvement in systemic disease |
| Q92605460 | Mesenchymal stem cells alleviate liver injury induced by chronic-binge ethanol feeding in mice via release of TSG6 and suppression of STAT3 activation |
| Q26769611 | Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies? |
| Q38336428 | MicroRNAs in alcoholic liver disease |
| Q38034068 | Microbial translocation in HIV infection: causes, consequences and treatment opportunities |
| Q26740192 | Microbiota-based treatments in alcoholic liver disease |
| Q43656405 | Modeling xenobiotic susceptibility to hepatotoxicity using an in vitro oxidative stress inflammation model |
| Q28541325 | Multifactorial comparative proteomic study of cytochrome P450 2E1 function in chronic alcohol administration |
| Q35931190 | NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. |
| Q35808323 | NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma |
| Q38083975 | Neuroimmune signaling: a key component of alcohol abuse |
| Q41706852 | Oral Co-administration of Soy-derived Extracts with Alcohol or with Sugar-sweetened Beverages Exerts Liver and Sugar Protective Effects |
| Q35829841 | Oxidative stress and inflammation: essential partners in alcoholic liver disease. |
| Q98613138 | Oxidative stress in alcohol-related liver disease |
| Q41947111 | Pathogenesis of alcoholic hepatitis: Role of inflammatory signaling and oxidative stress |
| Q91281532 | Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice |
| Q41919647 | Phosphorylation of Icariin Can Alleviate the Oxidative Stress Caused by the Duck Hepatitis Virus A through Mitogen-Activated Protein Kinases Signaling Pathways |
| Q37696229 | Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production |
| Q38301574 | Potent effects of dioscin against obesity in mice |
| Q40952166 | Preventing Gut Leakiness and Endotoxemia Contributes to the Protective Effect of Zinc on Alcohol-Induced Steatohepatitis in Rats |
| Q38015800 | Probiotics in the treatment of the liver diseases |
| Q90384468 | Protective Effects of Fucoxanthin against Alcoholic Liver Injury by Activation of Nrf2-Mediated Antioxidant Defense and Inhibition of TLR4-Mediated Inflammation |
| Q40046189 | Protective Effects of Hydrolyzed Nucleoproteins from Salmon Milt against Ethanol-Induced Liver Injury in Rats. |
| Q57821804 | Protective Effects of Taraxasterol against Ethanol-Induced Liver Injury by Regulating CYP2E1/Nrf2/HO-1 and NF-B Signaling Pathways in Mice |
| Q58595354 | Protective effect of ultrasonication-processed ginseng berry extract on the D-galactosamine/lipopolysaccharide-induced liver injury model in rats |
| Q39328599 | Protective effects of dioscin against alcohol-induced liver injury |
| Q42317974 | Protective role of licochalcone B against ethanol-induced hepatotoxicity through regulation of Erk signaling |
| Q90599568 | Pyroptosis in Liver Disease: New Insights into Disease Mechanisms |
| Q38244572 | Redox regulation of inflammation: old elements, a new story |
| Q47556931 | Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease |
| Q34600023 | Role of IRAK-M in alcohol induced liver injury |
| Q98159172 | Role of Mesencephalic Astrocyte-Derived Neurotrophic Factor in Alcohol-Induced Liver Injury |
| Q83162003 | Role of TLR4 in ethanol effects on innate and adaptive immune responses in peritoneal macrophages |
| Q26746981 | Role of Transcription Factors in Steatohepatitis and Hypertension after Ethanol: The Epicenter of Metabolism |
| Q57067876 | Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease |
| Q45121196 | Role of monokine induced by interferon-γ in liver injury induced by hepatitis B virus in mice |
| Q38116979 | Role of oxidative stress in the pathogenesis of alcohol-induced liver disease |
| Q47353167 | Role of the innate immune system in the neuropathological consequences induced by adolescent binge drinking. |
| Q38218115 | Role of toll-like receptors in immune activation and tolerance in the liver |
| Q89185978 | Shanxi Aged Vinegar Protects against Alcohol-Induced Liver Injury via Activating Nrf2-Mediated Antioxidant and Inhibiting TLR4-Induced Inflammatory Response |
| Q89965589 | Short-Chain Alcohols Upregulate GILZ Gene Expression and Attenuate LPS-Induced Septic Immune Response |
| Q48203151 | Signalling Profiles of Blood Leucocytes in Sepsis and in Acute Pancreatitis in Relation to Disease Severity |
| Q36254212 | Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice |
| Q39419036 | Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients. |
| Q46005086 | Summary of the 2016 Alcohol and Immunology Research Interest Group (AIRIG) meeting. |
| Q54511206 | Suppression of autophagy sensitizes Kupffer cells to endotoxin. |
| Q41847903 | TLR4 signaling and the inhibition of liver hepcidin expression by alcohol |
| Q91632128 | Tamarix chinensis Lour inhibits chronic ethanol-induced liver injury in mice |
| Q36423119 | Telomerase reverse transcriptase acts in a feedback loop with NF-κB pathway to regulate macrophage polarization in alcoholic liver disease |
| Q26773226 | The Role of Innate Immunity in Alcoholic Liver Disease |
| Q35193292 | The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings |
| Q37595286 | The functional role of microRNAs in alcoholic liver injury |
| Q50245155 | The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis. |
| Q88959543 | The murine hepatic sequelae of long-term ethanol consumption are sex-specific and exacerbated by Aldh1b1 loss |
| Q28392224 | The potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinoma |
| Q37778758 | The potential of cytokines as safety biomarkers for drug-induced liver injury |
| Q33997351 | The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis |
| Q33977054 | The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes |
| Q38074434 | The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension |
| Q42557231 | The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease |
| Q37834042 | The unfolding web of innate immune dysregulation in alcoholic liver injury |
| Q36236676 | Thromboxane inhibitors attenuate inflammatory and fibrotic changes in rat liver despite continued ethanol administrations |
| Q51056516 | Toll-Like Receptor 4-Independent Carbon Tetrachloride-Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice: Role of Hepatic Stellate Cells. |
| Q34321742 | Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis |
| Q41745892 | Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury |
| Q34106192 | Toll-like receptors in the pathogenesis of alcoholic liver disease. |
| Q60949531 | Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development |
| Q55069197 | Transforming growth factor-β-activated kinase 1 resistance limits glucocorticoid responsiveness to Toll-like receptor 4-mediated inflammation. |
| Q26860731 | Trauma equals danger--damage control by the immune system |
| Q37707739 | Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase |
| Q34489050 | Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease |
| Q42117871 | You deserve what you eat: lessons learned from the study of the melanin-concentrating hormone (MCH)-deficient mice |
| Q47410103 | Zinc deficiency as a mediator of toxic effects of alcohol abuse |
| Q30359251 | miR-217 regulates ethanol-induced hepatic inflammation by disrupting sirtuin 1-lipin-1 signaling. |
| Q92132026 | microRNA-155 Modulates Hepatic Stellate Cell Proliferation, Apoptosis, and Cell Cycle Progression in Rats With Alcoholic Hepatitis via the MAPK Signaling Pathway Through Targeting SOCS1 |
| Q35783512 | β-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice |
Search more.